BIOMARKERS AND ASSAYS FOR THE TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

Matvey E. Lukashev

发明人:

Matvey E. Lukashev,Pradeep Bista,Weike Zeng

申请号：

US12443936

公开号：

US20120282245A1

申请日:

2007.10.03

申请国别(地区):

US

年份:

2012

代理人:

摘要：

This invention features methods for prognosticating the efficacy of a cancer treatment comprising administration of a lymphotoxin-β receptor (LT-β-R) using TRAF3, TRAF2, and/or p53 markers, as well as combination therapies that include a composition that activates lymphotoxin-beta receptor signaling in combination with one or more other agents.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/